Company Intelligence Profile
Cyclops Medtech Private Limited
Cyclops Medtech is a Bengaluru-based medical-devices company building vestibular (balance-disorder) assessment and rehabilitation systems.
Last updated 11 August 2026
Cyclops Medtech is a Bengaluru-based medical-devices company specializing in vestibular assessment and rehabilitation systems. With flagship products like BalancEye and Postura, the company serves over 900 clinics and hospitals in 14 countries. In FY2023, Cyclops Medtech reported a revenue of ₹4.89 Crore, marking a 19.41% growth year-over-year.
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
See what AICA knows about Cyclops Medtech
Deeper analysis, financial signals and peer comparisons.
Company Identity
| Registered name | Cyclops Medtech Private Limited |
|---|---|
| CIN | U74900KA2015PTC078575 |
| PAN | AAFCC9247D |
| Status | Active (Private Limited Company), Unlisted |
| Listing | No — unlisted private limited company |
| Incorporated | 29 January 2015 |
| ROC | RoC Karnataka (Bangalore) |
| Sector (NIC) | Healthcare / healthtech — medical devices for vestibular (balance) disorder diagnosis and rehabilitation |
| Registered address | No. 82, Swamy Vivekananda Road, 2nd Cross, Narayana Nagar, 1st Block, Kanakapura Road, Doddakallasandra, Municipal Corporation Layout, Bengaluru, Karnataka – 560062 |
| Authorized capital | ₹5.0 Crore |
| Paid-up capital | ₹1.57 Lakh (Issued & Subscribed also ₹1.57 Lakh) |
Business Overview
- Cyclops Medtech is a Bengaluru-based medical-devices company building vestibular (balance-disorder) assessment and rehabilitation systems
- Flagship products per the official site (cyclopsmedtech.com): BalancEye VOG (videonystagmography), BalancEye vHIT (video head impulse test), BalancEye VRT (VR-based vestibular rehabilitation), and Postura (stabilometry / smart balance board)
- The company states its devices are used across neurotology, neurology, physical therapy, audiology and ophthalmology, reaching 900+ clinics/hospitals in 14 countries with 1.5 million+ tests/therapies delivered (company self-reported claim, not independently verified)
- Team is described as ~40 people across medical, scientific, engineering and business functions
- Source: cyclopsmedtech.com (official site)
Directors
Per Tofler (names + DINs) and corroborated by name/appointment-date match on TheCompanyCheck:
| Name | DIN | Role | Appointed |
|---|---|---|---|
| Ravi Chandran Nayar | 07043276 | Director & Co-founder | 29 Jan 2015 |
| Dorasala Rammanna Srinivas | 07043290 | Director | 29 Jan 2015 |
| Niranjan Mysore Subbarao | 03032895 | Director & Co-founder & CEO | 29 Jan 2015 |
| Chandanmal Pukhraj Bothra | 00023108 | Nominee Director | 09 Jul 2018 |
Financials
Conflicting-period, partially locked data:
| TheCompanyCheck | FY2023 (year ended 31 Mar 2023) Revenue ₹4.89 Crore, +19.41% YoY. EBITDA/PAT figures shown as "locked in full report" (paywalled). Employees ~25 (Mar 2024) |
|---|---|
| Tofler | shows FY2022 percentage changes only (paywalled absolutes): Total Revenue +74.06% YoY, EBITDA +180.54%, Net Profit +760.5%, Net Worth +16.81%, Borrowings −100%, Total Assets +24.16%. Ratios for FY2022: Operating Margin 6.36%, Net Profit Margin 14.14%, ROE 12.44%, ROCE 10.76%, Debt/Equity 0.0 |
No absolute EBITDA/PAT/net-worth/borrowings figures were obtainable from free-tier sources for either FY. Presumed standalone (no consolidation indicated for a single-entity private company; not explicitly stated by either source). Status: partial.
Funding
- No funding-round press coverage found on Entrackr or Inc42 (searched, zero results for "Cyclops Medtech")
- However, the company's own website lists "Nokha Holdings" and "Unitus Ventures" as organizational board representatives, strongly implying both have taken an equity/board position — but no round name, amount, date, or valuation could be confirmed from any source
- Status: partial
Charges / Loans
- One open charge — Lender/Charge holder: HDFC Bank Limited
- Amount: ₹0.70 Crore (₹70 Lakh)
- Date created/modified: 12 October 2023
- Status: Open (not satisfied)
- No other charges (satisfied or open) reported on either source
Competitors
Not source-confirmed via a named competitor list (no analyst/press comparison found); based on product-category knowledge (vestibular/balance-disorder diagnostic and rehabilitation devices — VOG, vHIT, VRT-based vestibular rehab, posturography), plausible peers are:
- Interacoustics (Denmark, part of Demant) — large, global scale, vestibular/audiology diagnostics
- Natus Medical / Otometrics — large, global scale, ENG/VNG and balance systems
- Micromedical Technologies (Interacoustics-owned, US) — mid-large scale, VNG/rotary chair systems
- Bertec Corporation (US) — mid scale, posturography/balance-assessment platforms
- Trivitron Healthcare (India) — large diversified Indian medtech, broader portfolio (not vestibular-specialist but an Indian medtech peer/comparator)
- Meril Life Sciences (India) — large diversified Indian medtech, broader portfolio (comparator only)
Treat this list as directional/category-inferred, not a verified "who competes directly" roster.
Frequently Asked Questions
What does Cyclops Medtech Private Limited do?
What is the CIN of Cyclops Medtech Private Limited?
Where is Cyclops Medtech Private Limited registered?
When was Cyclops Medtech Private Limited incorporated?
Recur Market
Which lenders fit a company like Cyclops Medtech Private Limited?
Answer a few questions about your business and see which banks and NBFCs match, with indicative rates.
Explore on Recur Club
More from Recur Club
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.